Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
0.90 EUR
149.69 M EUR
957.09 M EUR
27.13 M
About SCHOTT PHARMA AG & CO. KGAA
Sector
Industry
CEO
Andreas Reisse
Website
Headquarters
Mainz
Founded
2022
ISIN
DE000A3ENQ51
FIGI
BBG01SSK1CP7
SCHOTT Pharma AG & Co. KgaA engages in the provision of designing drug containment and drug delivery solutions. It operates through the Drug Containment Solutions and Drug Delivery Systems segments. The Drug Containment Solutions segment focuses on the products from the Core category that currently make up the largest part of the DCS product portfolio. The Drug Delivery Systems segment includes products that are characterized by improved product functionality and belong to the HVS product portfolio. It offers a wide range of advanced drug containment solutions and delivery systems for inject able drugs that supply to the pharmaceutical and biotechnology industries. The company was founded on May 10, 2022 and is headquartered in Mainz, Germany.
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Related stocks
Frequently Asked Questions
The current price of 1SXP is 23.24 EUR — it has increased by 1.03% in the past 24 hours. Watch SCHOTT PHARMA stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on MIL exchange SCHOTT PHARMA stocks are traded under the ticker 1SXP.
1SXP stock has fallen by −4.83% compared to the previous week, the month change is a −6.93% fall, over the last year SCHOTT PHARMA has showed a −8.50% decrease.
We've gathered analysts' opinions on SCHOTT PHARMA future price: according to them, 1SXP price has a max estimate of 37.00 EUR and a min estimate of 20.00 EUR. Watch 1SXP chart and read a more detailed SCHOTT PHARMA stock forecast: see what analysts think of SCHOTT PHARMA and suggest that you do with its stocks.
1SXP reached its all-time high on Mar 7, 2025 with the price of 25.40 EUR, and its all-time low was 24.84 EUR and was reached on Mar 10, 2025. View more price dynamics on 1SXP chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
1SXP stock is 1.72% volatile and has beta coefficient of 0.56. Track SCHOTT PHARMA stock price on the chart and check out the list of the most volatile stocks — is SCHOTT PHARMA there?
Today SCHOTT PHARMA has the market capitalization of 3.51 B, it has increased by 2.56% over the last week.
Yes, you can track SCHOTT PHARMA financials in yearly and quarterly reports right on TradingView.
SCHOTT PHARMA is going to release the next earnings report on May 15, 2025. Keep track of upcoming events with our Earnings Calendar.
1SXP earnings for the last quarter are 0.19 EUR per share, whereas the estimation was 0.20 EUR resulting in a −2.61% surprise. The estimated earnings for the next quarter are 0.22 EUR per share. See more details about SCHOTT PHARMA earnings.
SCHOTT PHARMA revenue for the last quarter amounts to 230.00 M EUR, despite the estimated figure of 229.24 M EUR. In the next quarter, revenue is expected to reach 240.88 M EUR.
1SXP net income for the last quarter is 28.89 M EUR, while the quarter before that showed 33.97 M EUR of net income which accounts for −14.95% change. Track more SCHOTT PHARMA financial stats to get the full picture.
Yes, 1SXP dividends are paid annually. The last dividend per share was 0.16 EUR. As of today, Dividend Yield (TTM)% is 0.69%. Tracking SCHOTT PHARMA dividends might help you take more informed decisions.
SCHOTT PHARMA dividend yield was 0.52% in 2024, and payout ratio reached 16.10%. The year before the numbers were 0.47% and 14.88% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Apr 2, 2025, the company has 4.69 K employees. See our rating of the largest employees — is SCHOTT PHARMA on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. SCHOTT PHARMA EBITDA is 233.26 M EUR, and current EBITDA margin is 24.66%. See more stats in SCHOTT PHARMA financial statements.
Like other stocks, 1SXP shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SCHOTT PHARMA stock right from TradingView charts — choose your broker and connect to your account.